Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1950 1
1953 1
1954 1
1969 1
1970 3
1972 1
1974 1
1976 1
1977 1
1978 1
1980 1
1982 1
1983 1
1989 1
1992 2
1993 1
1996 2
1997 3
2000 1
2001 2
2002 3
2003 1
2005 7
2006 2
2007 4
2008 3
2009 5
2010 5
2011 3
2012 6
2013 8
2014 6
2015 6
2016 14
2017 7
2018 14
2019 7
2020 9
2021 12
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
The coding capacity of SARS-CoV-2.
Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-Ronen Y, Tamir H, Achdout H, Stein D, Israeli O, Beth-Din A, Melamed S, Weiss S, Israely T, Paran N, Schwartz M, Stern-Ginossar N. Finkel Y, et al. Among authors: morgenstern d. Nature. 2021 Jan;589(7840):125-130. doi: 10.1038/s41586-020-2739-1. Epub 2020 Sep 9. Nature. 2021. PMID: 32906143
Theranostics in Neuroblastoma.
Rafael MS, Cohen-Gogo S, Irwin MS, Vali R, Shammas A, Morgenstern DA. Rafael MS, et al. Among authors: morgenstern da. PET Clin. 2021 Jul;16(3):419-427. doi: 10.1016/j.cpet.2021.03.006. PET Clin. 2021. PMID: 34053585 Review.
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.
Das A, Sudhaman S, Morgenstern D, Coblentz A, Chung J, Stone SC, Alsafwani N, Liu ZA, Karsaneh OAA, Soleimani S, Ladany H, Chen D, Zatzman M, Cabric V, Nobre L, Bianchi V, Edwards M, Sambira Nahum LC, Ercan AB, Nabbi A, Constantini S, Dvir R, Yalon-Oren M, Campino GA, Caspi S, Larouche V, Reddy A, Osborn M, Mason G, Lindhorst S, Bronsema A, Magimairajan V, Opocher E, De Mola RL, Sabel M, Frojd C, Sumerauer D, Samuel D, Cole K, Chiaravalli S, Massimino M, Tomboc P, Ziegler DS, George B, Van Damme A, Hijiya N, Gass D, McGee RB, Mordechai O, Bowers DC, Laetsch TW, Lossos A, Blumenthal DT, Sarosiek T, Yen LY, Knipstein J, Bendel A, Hoffman LM, Luna-Fineman S, Zimmermann S, Scheers I, Nichols KE, Zapotocky M, Hansford JR, Maris JM, Dirks P, Taylor MD, Kulkarni AV, Shroff M, Tsang DS, Villani A, Xu W, Aronson M, Durno C, Shlien A, Malkin D, Getz G, Maruvka YE, Ohashi PS, Hawkins C, Pugh TJ, Bouffet E, Tabori U. Das A, et al. Among authors: morgenstern d. Nat Med. 2022 Jan;28(1):125-135. doi: 10.1038/s41591-021-01581-6. Epub 2022 Jan 6. Nat Med. 2022. PMID: 34992263 Free PMC article.
Hamstring injuries.
Mann G, Shabat S, Friedman A, Morgenstern D, Constantini N, Lowe J, Nyska M. Mann G, et al. Among authors: morgenstern d. Orthopedics. 2007 Jul;30(7):536-40; quiz 541-2. doi: 10.3928/01477447-20070701-08. Orthopedics. 2007. PMID: 17672153 Review. No abstract available.
Hip Arthroscopy: extra-articular Procedures.
Perets I, Rybalko D, Mu BH, Friedman A, Morgenstern DR, Domb BG. Perets I, et al. Among authors: morgenstern dr. Hip Int. 2019 Jul;29(4):346-354. doi: 10.1177/1120700019840729. Epub 2019 Apr 21. Hip Int. 2019. PMID: 31006272 Review.
The challenge of defining "ultra-high-risk" neuroblastoma.
Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D, London WB, Irwin MS. Morgenstern DA, et al. Pediatr Blood Cancer. 2019 Apr;66(4):e27556. doi: 10.1002/pbc.27556. Epub 2018 Nov 26. Pediatr Blood Cancer. 2019. PMID: 30479064 Review.
The Role of Surgery in High-risk Neuroblastoma.
Ryan AL, Akinkuotu A, Pierro A, Morgenstern DA, Irwin MS. Ryan AL, et al. Among authors: morgenstern da. J Pediatr Hematol Oncol. 2020 Jan;42(1):1-7. doi: 10.1097/MPH.0000000000001607. J Pediatr Hematol Oncol. 2020. PMID: 31599856 Review.
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P, Pasqualini C, Pötschger U, Sangüesa C, Castellani MR, Cañete A, Luksch R, Elliot M, Schreier G, Kropf M, Morgenstern D, Papadakis V, Ash S, Ruud E, Brock P, Wieczorek A, Kogner P, Trahair T, Ambros P, Boterberg T, Castel V, Valteau-Couanet D, Ladenstein R. Berlanga P, et al. Among authors: morgenstern d. Eur J Cancer. 2021 Feb;144:1-8. doi: 10.1016/j.ejca.2020.10.020. Epub 2020 Dec 11. Eur J Cancer. 2021. PMID: 33316634 Free article. Clinical Trial.
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, Kim SY, Verdugo M, Lash-Fleming L, Zwaan CM, Vormoor J. Place AE, et al. Among authors: morgenstern da. Future Oncol. 2018 Sep;14(21):2115-2129. doi: 10.2217/fon-2018-0121. Epub 2018 Mar 29. Future Oncol. 2018. PMID: 29595064 Free article. Clinical Trial.
148 results